Shalini Sharp
CIK 1377202 · EVP, Finance · last filed 2026-05-29
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$8.71M
Companies
11
Total Filings
138
Lifetime Open-Market Net
-$18.05M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NBIX | Director | 4,088 | $159.76 | $653.1K | -$156.9K | 9 | 2026-05-29 |
| SEPN | Director | — | $35.95 | — | $0 | 1 | 2025-06-20 |
| OGN | Director | 2 | $13.44 | $27 | $0 | 5 | 2025-06-16 |
| ONC | Director | 19,136 | $264.48 | $5.06M | $0 | 1 | 2025-05-22 |
| BeOne Medicines Ltd. (BGNE) Delisted | Director | 8,151 | $184.71 | $1.51M | $0 | 1 | 2024-10-02 |
| Mirati Therapeutics, Inc. (MRTX) Delisted | Director | 12,060 | $58.70 | $707.9K | $0 | 5 | 2024-01-23 |
| STRO | Director | — | $28.80 | — | $0 | 5 | 2022-06-08 |
| DTIL | Director | — | $6.10 | — | $0 | 2 | 2021-05-12 |
| Nuvation Bio Inc. (NUVB.WS) Delisted | Director | 35,000 | $0.01 | $178 | $0 | 1 | 2021-02-26 |
| RARE | EVP, Finance | 97,812 | $24.35 | $2.38M | -$17.81M | 53 | 2020-10-16 |
| AGEN | Director | 185,581 | $3.30 | $612.4K | -$89.0K | 52 | 2018-06-22 |
Recent Filings · Page 10 of 14
138 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2014-09-19 | RARE | Sell (S) | −4,000 | -$224.0K | EDGAR |
| 2014-08-19 | RARE | Sell (S) | −4,000 | -$215.9K | EDGAR |
| 2014-02-03 | RARE | Buy (P) | +4,500 | $94.5K | EDGAR |
| 2013-06-17 | AGEN | Grant (A) | — | $0 | EDGAR |
| 2013-02-01 | AGEN | Sell (S) | −288 | -$1.3K | EDGAR |
| 2013-01-29 | AGEN | Grant (A) | +625 | $2.7K | EDGAR |
| 2012-11-01 | AGEN | Sell (S) | −288 | -$1.3K | EDGAR |
| 2012-10-29 | AGEN | Grant (A) | +625 | $2.8K | EDGAR |
| 2012-09-14 | AGEN | Mixed | +4,035 | $0 | EDGAR |
| 2012-08-31 | AGEN | Sell (S) | −288 | -$1.3K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.